# TME Therapeutics Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tme-therapeutics-co

- Industry: Biotechnology
- Headquarters: Incheon, South Korea
- Website: www.tmet.co.kr
- Total disclosed funding: $0.4M
- Latest round: Seed (Mar 21, 2023)
- Investors on record: 2

## About

Based in Incheon, South Korea, and founded in 2020, TME Therapeutics Co., Ltd. operates as a developer of a growth-based cell production and control technology used in the production process of cultured meat products to reduce its production cost. In March 2023, TME Therapeutics Co., Ltd. raised KRW 500 million in seed funding from Korea Tech Incubator for Startup, with participation from Big Bang Angels, being selected for Accelerator Investment-Driven Tech Incubator Program.

TME Therapeutics Co., Ltd.'s goal is to make advances in the field of stem-cell-based cultured cell therapy. The company specialize in providing coated surfaces that allow stem cells, such as mesenchymal stem cells, satellite stem cells, and neural stem cells, to connect and expand.  The company provides solutions that give researchers and practitioners access to stem cell expansion possibilities that are properly controlled and described.

The company plans to use the March 2023 funding to establish a process of increasing stem cells in cultured meats to reduce its production cost and aim to produce it on a commercial scale by 2025.

## Funding rounds

- Seed, Mar 21, 2023, $0.4M — BigBang Angels, Korea Tech Incubator for Startup

## Investors

- BigBang Angels (https://capitalatlas.ai/funds/bigbang-angels) — Seed
- Korea Tech Incubator for Startup — Seed